Hangzhou, China

Baocai Sun

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jhm Biopharmaceutical (Hangzhou) Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Baocai Sun. Retrieved from https://idiyas.com/inventor/baocai-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Baocai Sun - Innovator in Biopharmaceuticals

Introduction

Baocai Sun is an accomplished inventor based in Hangzhou, China. He is currently associated with JHM Biopharmaceutical (Hangzhou) Co., Ltd. Baocai Sun has made significant contributions to the field of biopharmaceuticals, particularly in the development of growth hormone fusion proteins.

Latest Patent Applications

Baocai Sun's notable patent application is titled "Growth Hormone Fusion Protein and Preparation Method and Use Thereof." This application describes a growth hormone fusion protein that includes a double-stranded structure with a first and second constant region Fc segment. The growth hormone linked to the first constant region Fc segment is designed without methionine at its N-terminus. The innovation aims to prolong the in vivo half-life of the growth hormone while ensuring that the active site remains unaffected by steric hindrance, thus providing stronger activity and higher safety.

Conclusion

Baocai Sun's work in the biopharmaceutical sector showcases his innovative approach to enhancing the efficacy and safety of growth hormone treatments. His contributions are poised to make a significant impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…